• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对无再灌注情况下的心肌缺血损伤。

Targeting myocardial ischaemic injury in the absence of reperfusion.

机构信息

The Hatter Cardiovascular Institute, 67 Chenies Mews, London, WC1E 6HX, UK.

出版信息

Basic Res Cardiol. 2020 Oct 14;115(6):63. doi: 10.1007/s00395-020-00825-9.

DOI:10.1007/s00395-020-00825-9
PMID:33057804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7560937/
Abstract

Sudden myocardial ischaemia causes an acute coronary syndrome. In the case of ST-elevation myocardial infarction (STEMI), this is usually caused by the acute rupture of atherosclerotic plaque and obstruction of a coronary artery. Timely restoration of blood flow can reduce infarct size, but ischaemic regions of myocardium remain in up to two-thirds of patients due to microvascular obstruction (MVO). Experimentally, cardioprotective strategies can limit infarct size, but these are primarily intended to target reperfusion injury. Here, we address the question of whether it is possible to specifically prevent ischaemic injury, for example in models of chronic coronary artery occlusion. Two main types of intervention are identified: those that preserve ATP levels by reducing myocardial oxygen consumption, (e.g. hypothermia; cardiac unloading; a reduction in heart rate or contractility; or ischaemic preconditioning), and those that increase myocardial oxygen/blood supply (e.g. collateral vessel dilation). An important consideration in these studies is the method used to assess infarct size, which is not straightforward in the absence of reperfusion. After several hours, most of the ischaemic area is likely to become infarcted, unless it is supplied by pre-formed collateral vessels. Therefore, therapies that stimulate the formation of new collaterals can potentially limit injury during subsequent exposure to ischaemia. After a prolonged period of ischaemia, the heart undergoes a remodelling process. Interventions, such as those targeting inflammation, may prevent adverse remodelling. Finally, harnessing of the endogenous process of myocardial regeneration has the potential to restore cardiomyocytes lost during infarction.

摘要

急性心肌缺血导致急性冠状动脉综合征。在 ST 段抬高型心肌梗死(STEMI)的情况下,这通常是由动脉粥样硬化斑块的急性破裂和冠状动脉阻塞引起的。及时恢复血流可以减少梗死面积,但由于微血管阻塞(MVO),多达三分之二的患者仍存在缺血心肌区域。在实验中,心脏保护策略可以限制梗死面积,但这些策略主要旨在针对再灌注损伤。在这里,我们探讨了是否有可能专门预防缺血性损伤,例如在慢性冠状动脉闭塞模型中。确定了两种主要的干预类型:通过降低心肌耗氧量来维持 ATP 水平的干预措施(例如低温;心脏卸载;降低心率或收缩性;或缺血预处理),以及增加心肌氧/血液供应的干预措施(例如侧支血管扩张)。在这些研究中,一个重要的考虑因素是评估梗死面积的方法,在没有再灌注的情况下,这并不简单。数小时后,除非缺血区域由预先形成的侧支血管供应,否则大部分缺血区域很可能会发生梗死。因此,刺激新侧支形成的治疗方法有可能在随后暴露于缺血时限制损伤。在长时间缺血后,心脏会经历重塑过程。干预措施,如针对炎症的干预措施,可能会防止不良重塑。最后,利用心肌再生的内源性过程有可能恢复梗死后失去的心肌细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/45444d422e71/395_2020_825_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/08062bb5bdca/395_2020_825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/877c670dde7d/395_2020_825_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/a12ac459bd69/395_2020_825_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/aa4982ff844a/395_2020_825_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/bad4d04fb344/395_2020_825_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/45444d422e71/395_2020_825_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/08062bb5bdca/395_2020_825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/877c670dde7d/395_2020_825_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/a12ac459bd69/395_2020_825_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/aa4982ff844a/395_2020_825_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/bad4d04fb344/395_2020_825_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6070/7560937/45444d422e71/395_2020_825_Fig6_HTML.jpg

相似文献

1
Targeting myocardial ischaemic injury in the absence of reperfusion.针对无再灌注情况下的心肌缺血损伤。
Basic Res Cardiol. 2020 Oct 14;115(6):63. doi: 10.1007/s00395-020-00825-9.
2
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.在急性心肌缺血/再灌注损伤中的冠状循环:心脏保护的靶点。
Cardiovasc Res. 2019 Jun 1;115(7):1143-1155. doi: 10.1093/cvr/cvy286.
3
Optimized Treatment of ST-Elevation Myocardial Infarction.优化 ST 段抬高型心肌梗死的治疗。
Circ Res. 2019 Jul 5;125(2):245-258. doi: 10.1161/CIRCRESAHA.119.315344. Epub 2019 Jul 3.
4
Preconditioning improves myocardial function and reflow, but not vasodilator reactivity, after ischaemia and reperfusion in anaesthetized dogs.预处理可改善麻醉犬缺血再灌注后的心肌功能和再灌注,但不能改善血管舒张反应性。
Clin Exp Pharmacol Physiol. 1998 Jul-Aug;25(7-8):552-8. doi: 10.1111/j.1440-1681.1998.tb02250.x.
5
The reduction of infarct size--forty years of research.梗死面积的缩小——四十年的研究
Rev Port Cardiol. 2010 Jun;29(6):1037-53.
6
The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.急性心肌梗死的病理生理学和再灌注后保护策略:持续面临的挑战。
Eur Heart J. 2017 Mar 14;38(11):774-784. doi: 10.1093/eurheartj/ehw224.
7
Innate immunity as a target for acute cardioprotection.先天免疫作为急性心脏保护的靶点。
Cardiovasc Res. 2019 Jun 1;115(7):1131-1142. doi: 10.1093/cvr/cvy304.
8
Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.梗死前心绞痛和冠状动脉侧支血流对ST段抬高型心肌梗死患者远程缺血预处理疗效的影响:一项随机对照试验的事后亚组分析
BMJ Open. 2016 Nov 24;6(11):e013314. doi: 10.1136/bmjopen-2016-013314.
9
NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.NHLBI 赞助的 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗中后处理的随机试验。
Circ Res. 2019 Mar;124(5):769-778. doi: 10.1161/CIRCRESAHA.118.314060.
10
Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.再灌注对缺血心肌的挽救作用:闭塞期间侧支血流和心肌需氧量的重要性。
Cardiovasc Res. 1986 Jun;20(6):403-14. doi: 10.1093/cvr/20.6.403.

引用本文的文献

1
Interpretable machine learning model for predicting myocardial injury in intensive care unit patients using SHapley Additive exPlanations analysis.使用SHapley加性解释分析预测重症监护病房患者心肌损伤的可解释机器学习模型。
Sci Prog. 2025 Jul-Sep;108(3):368504251370452. doi: 10.1177/00368504251370452. Epub 2025 Aug 25.
2
Mitochondria-targeted ROS scavenger JP4-039 improves cardiac function in a post-myocardial infarction animal model and induces angiogenesis in vitro.线粒体靶向活性氧清除剂JP4-039改善心肌梗死后动物模型的心脏功能并在体外诱导血管生成。
PLoS One. 2025 Apr 24;20(4):e0320703. doi: 10.1371/journal.pone.0320703. eCollection 2025.
3

本文引用的文献

1
Transvalvular Ventricular Unloading Before Reperfusion in Acute Myocardial Infarction.经皮二尖瓣瓣环成形术在急性心肌梗死再灌注前减轻心室负荷的效果。
J Am Coll Cardiol. 2020 Aug 11;76(6):684-699. doi: 10.1016/j.jacc.2020.06.031.
2
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.心肌缺血再灌注损伤及心肌保护的展望。
Nat Rev Cardiol. 2020 Dec;17(12):773-789. doi: 10.1038/s41569-020-0403-y. Epub 2020 Jul 3.
3
Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin.
Danqi soft caspule alleviates myocardial ischemia-reperfusion injury induced cardiomyocyte apoptosis by attenuating mitochondrial fission.
丹芪软胶囊通过减轻线粒体分裂来减轻心肌缺血再灌注损伤诱导的心肌细胞凋亡。
Front Pharmacol. 2025 Mar 12;16:1526253. doi: 10.3389/fphar.2025.1526253. eCollection 2025.
4
Nutritional Advantages of Walnut ( L.) for Cardiovascular Diseases: A Comprehensive Review.核桃对心血管疾病的营养优势:综述
Food Sci Nutr. 2024 Dec 30;13(1):e4526. doi: 10.1002/fsn3.4526. eCollection 2025 Jan.
5
Unraveling the role of lactate-related genes in myocardial infarction.解析乳酸相关基因在心肌梗死中的作用。
Heliyon. 2024 Sep 19;10(18):e38152. doi: 10.1016/j.heliyon.2024.e38152. eCollection 2024 Sep 30.
6
Abatacept: A Promising Repurposed Solution for Myocardial Infarction-Induced Inflammation in Rat Models.阿巴西普:一种有前景的再利用解决方案,用于治疗大鼠模型中心肌梗死诱导的炎症。
Oxid Med Cell Longev. 2024 Mar 13;2024:3534104. doi: 10.1155/2024/3534104. eCollection 2024.
7
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria.根据改善心脏保护疗法的临床前评估(IMPACT)标准,重新评估大麻素对缺血再灌注损伤的心脏保护作用。
Front Pharmacol. 2024 May 30;15:1382995. doi: 10.3389/fphar.2024.1382995. eCollection 2024.
8
Ischemia-induced cardiac dysfunction is exacerbated in adiponectin-knockout mice due to impaired autophagy flux.由于自噬通量受损,脂联素敲除小鼠的缺血性心脏功能障碍加剧。
Clin Transl Sci. 2024 Mar;17(3):e13758. doi: 10.1111/cts.13758.
9
Advanced technique of myocardial no-reflow quantification using indocyanine green.使用吲哚菁绿进行心肌无复流定量的先进技术。
Biomed Opt Express. 2024 Jan 17;15(2):818-833. doi: 10.1364/BOE.511912. eCollection 2024 Feb 1.
10
Time to presentation and mortality outcomes among patients with diabetes and acute myocardial infarction.糖尿病合并急性心肌梗死患者的就诊时间与死亡结局。
Korean J Intern Med. 2024 Jan;39(1):110-122. doi: 10.3904/kjim.2023.307. Epub 2023 Dec 11.
Exendin-4 通过激活β-arrestin-2、蛋白磷酸酶 2A、糖原合酶激酶-3 以及抑制β-连环蛋白来减轻大鼠急性心肌梗死后的远程心肌重构。
Cardiovasc Drugs Ther. 2021 Dec;35(6):1095-1110. doi: 10.1007/s10557-020-07006-9.
4
Mechanisms of Neonatal Heart Regeneration.新生儿心脏再生的机制。
Curr Cardiol Rep. 2020 Apr 24;22(5):33. doi: 10.1007/s11886-020-01282-5.
5
Oestrogen Receptor β Activation Protects Against Myocardial Infarction via Notch1 Signalling.雌激素受体 β 激活通过 Notch1 信号通路保护心肌免受梗死。
Cardiovasc Drugs Ther. 2020 Apr;34(2):165-178. doi: 10.1007/s10557-020-06949-3.
6
Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury.缺血再灌注损伤过程中心肌细胞死亡的线粒体和线粒体非依赖性途径。
J Cell Mol Med. 2020 Apr;24(7):3795-3806. doi: 10.1111/jcmm.15127. Epub 2020 Mar 10.
7
Natural Heart Regeneration in a Neonatal Rat Myocardial Infarction Model.新生大鼠心肌梗死模型中的自然心脏再生。
Cells. 2020 Jan 16;9(1):229. doi: 10.3390/cells9010229.
8
The changing face after acute myocardial infarction.急性心肌梗死后面容的变化。
Basic Res Cardiol. 2019 Dec 12;115(1):5. doi: 10.1007/s00395-019-0762-x.
9
Coronary microvascular obstruction: the new frontier in cardioprotection.冠状动脉微血管阻塞:心脏保护的新前沿。
Basic Res Cardiol. 2019 Oct 15;114(6):45. doi: 10.1007/s00395-019-0756-8.
10
Role of Caspase 1 in Ischemia/Reperfusion Injury of the Myocardium.Caspase-1 在心肌缺血/再灌注损伤中的作用。
J Cardiovasc Pharmacol. 2019 Sep;74(3):194-200. doi: 10.1097/FJC.0000000000000694.